26.07.21
Sputnik V vaccine approved in the largest African country
26.05.21
Slovakia approved the use of the Russian Sputnik V coronavirus vaccine
07.05.21
Sputnik Light, single dose vaccine, authorised for use in Russia
27.10.20
Russian investment fund submits application for accelerated approval of Sputnik V to WHO
Sputnik V vaccine approved in the largest African country
Rate the news:
Votes:  
40
26.07.2021 в 10:01

The use of the Sputnik V coronavirus vaccine has been approved in Nigeria, the Russian Direct Investment Fund (RDIF) said in a statement. The approval of the Russian Sputnik V vaccine against coronavirus was done by the National Agency for Food and Drug Administration and Control of Nigeria (NAFDAC). Nigeria has become the 68th country in the world to approve the Russian vaccine. Total population of all countries, where Sputnik V is approved for use, now exceeds 3.7 billion people, which is nearly half of the global population (including India, China, Brazil, UAE, Serbia, Hungary, Slovakia, Mexico and many others).

Sputnik V is based on a proven human adenoviral vectors platform and is successfully used in over 50 countries. Approval in Nigeria will make an important contribution to the country’s fight against the pandemic. According to RDIF, "Real world data obtained during vaccination with Sputnik V in a number of countries (Argentina, San-Marino, Serbia, Hungary, Bahrain, Mexico, UAE, Philippines among others) demonstrate that Sputnik V is one of the safest and most effective vaccines against coronavirus".

Sputnik V has a number of key advantages:

  • Efficacy of Sputnik V is 97.6% based on the analysis of data on the coronavirus infection rate among those in Russia vaccinated with both components of Sputnik V from December 5, 2020 to March 31, 2021;
  • The Sputnik V vaccine is based on a proven and well-studied platform of human adenoviral vectors, which cause the common cold and have been around for thousands of years.
  • Sputnik V uses two different vectors for the two shots in a course of vaccination, providing immunity with a longer duration than vaccines using the same delivery mechanism for both shots.
  • The safety, efficacy and lack of negative long-term effects of adenoviral vaccines have been proven by more than 250 clinical studies over two decades.
  • There are no strong allergies caused by Sputnik V.
  • The storage temperature of Sputnik V at +2+8 C means it can be stored in a conventional refrigerator without any need to invest in additional cold-chain infrastructure.
  • The price of Sputnik V is less than $10 per shot, making it affordable around the world.
#Russian export #sputnik v #Russian vaccine #coronavirus pandemic